Loading...

Zynerba Pharmaceuticals, Inc.

ZYNE•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.30
$0.03(2.36%)

Zynerba Pharmaceuticals, Inc. (ZYNE) Stock Chart & Performance Analysis

Explore Zynerba Pharmaceuticals, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
2.36%
3-Month Change
289.22%
6-Month Change
266.20%
Year-to-Date (YTD) Change
136.79%
1-Year Change
99.39%
3-Year Change
-64.67%
5-Year Change
-78.15%
All-Time (Max) Change
-92.00%

Analyzing Zynerba Pharmaceuticals, Inc. (ZYNE) Trends Across Multiple Time Frames

Zynerba Pharmaceuticals, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Zynerba Pharmaceuticals, Inc. stock shows N/A 1-day change, indicating low volatility, while its 5-day change of N/A suggests a broader trend. Over a 1-month period, a 2.36% rise could signal a pushback, whereas a 3-month rise of 289.22% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 266.20% and a YTD rise of 136.79% might concern investors, but a 1-year gain of 99.39% and a 3-year drop of -64.67% could indicate resilience. The 5-year surge of -78.15% highlights weak historical growth, while the all-time return of -92.00% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;